Potential application of the bulk RNA sequencing in routine MPN clinics
Bulk RNA-Seq is a feasible tool for routine clinical practice, providing comprehensive insights into the immune and genetic landscape of MPNs. This approach could enhance personalized treatment strategies and improve prognostic accuracy, ultimately contributing to better management of MPN patients.
Authors
- Yingying Wang (ORCID: https://orcid.org/0009-0002-4627-5336)
- Xuelan Zuo (ORCID: https://orcid.org/0000-0002-8577-347X)
- Xuedong Li (ORCID: https://orcid.org/0009-0005-3900-4484)
- Shenglong Li (ORCID: https://orcid.org/0000-0002-6296-5196)
- Mingli Xu
- Sanyun Wu
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1186/s12885-025-13947-x
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- National Natural Science Foundation of China
- Centre Scientifique et Technique du Bâtiment